KhabarCheckखबर चेक
← Top Stories

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Partially corroborated56

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

First seen · latest update · World · science

  • Indian mainstream 0
  • Indian independent 0
  • International 1
  • Official 0
Share

Coverage (1)

See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.